Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Novavax, Inc.
Pharmaceutical Preparation ManufacturingUnited States
Last verified 19 days agonovavax.com
Novavax, Inc., frequently referred to as Novavax, is a leading biopharmaceutical company headquartered in the US. Established in 1987, this innovative organisation specialises in the development of groundbreaking vaccines to combat serious infectious diseases globally.
The company is renowned for its proprietary recombinant protein-based vaccine technology and potent Matrix-M™ adjuvant. These platforms are central to its mission of creating highly effective vaccines, including its innovative COVID-19 vaccine.
Novavax’s dedication to advancing global public health through scientific innovation positions it as a key player in vaccine development. They continue to focus on addressing critical unmet medical needs worldwide.
25
DitchCarbon score
-17 vs industry average
Novavax, Inc.’s score of 25 is lower than 35% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Novavax, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Novavax, Inc. yet.
Novavax, Inc.'s reported carbon emissions
Novavax, Inc., a US-based pharmaceutical preparation manufacturing company, has not publicly disclosed its carbon emissions data. The company has not set any specific emissions reduction targets, including SBTi-validated targets. They are also not signatories to The Climate Pledge.
Assessing Novavax, Inc. as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Novavax, Inc. and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Novavax, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Novavax, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
2026 disclosureSee details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Novavax, Inc.19 days ago
25
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more